Type of Cancer
Leukemia
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of AG-120 in Combination with Azacitidine in Subjects ≥ 18 Years of Age with Previously Untreated and Relapsed Acute Myeloid Leukemia with an IDH1 Mutation Who Are Candidates for Non-intensive Therapy
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.